Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of Rob Koremans
Individual Investor

Rob Koremans

Overview

Edit Overview Section
Number of Current Board & Advisor Roles 1
CB Rank (Investor) 61,868
  • Primary Job Title Chief Executive Officer
  • Primary Organization 
    Recordati Logo
    Recordati
  • Investor Type 
    obfuscation
Rob Koremans is a CEO at Recordati. He attended Erasmus University Rotterdam.

Partner Investments

Edit Partner Investments Section
Number of Partner Investments 2
Announced Date  
Organization Name  
Investor Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
Proteon Pharmaceuticals Logo
Proteon Pharmaceuticals
Nutreco Logo
Nutreco
Yes
Venture Round - Proteon Pharmaceuticals Logo
Venture Round - Proteon Pharmaceuticals
obfuscation
obfuscation
Mosa Meat Logo
Mosa Meat
Nutreco Logo
Nutreco
—
Series B - Mosa Meat Logo
Series B - Mosa Meat
obfuscation

Jobs

Edit Jobs Section
Number of Current Jobs 2
Number of Past Jobs 1
Rob Koremans has 2 current jobs as Chief Executive Officer at Recordati and President and CEO, Global Specialty Medicines at Teva Pharmaceuticals. Additionally, Rob Koremans has had 1 past job as the CEO at Nutreco.
Organization Name  
Title At Company  
Start Date  
End Date  
Nutreco Logo
Nutreco
CEOAug 2018Aug 2021

Board and Advisor Roles

Edit Board and Advisor Roles Section
Number of Current Board & Advisor Roles 1
Rob Koremans is the Board Advisor at Nutreco.

Related Hubs

Edit Related Hubs Section
Hub Name  
CB Rank (Hub)  
Europe, Middle East, and Africa (EMEA) Acquired Companies With More Than $100M in Revenue Logo
Europe, Middle East, and Africa (EMEA) Acquired Companies With More Than $100M in Revenue
2,190
Europe, Middle East, and Africa (EMEA) Companies With More Than $100M in Revenue (Top 10K) Logo
Europe, Middle East, and Africa (EMEA) Companies With More Than $100M in Revenue (Top 10K)
575
Europe Companies With More Than $50M in Revenue (Top 10K) Logo
Europe Companies With More Than $50M in Revenue (Top 10K)
590
Health Care Acquired Companies With More Than 50 Employees Logo
Health Care Acquired Companies With More Than 50 Employees
2,074
Health Care Companies With More Than $10M in Revenue (Top 10K) Logo
Health Care Companies With More Than $10M in Revenue (Top 10K)
1,179
Europe, Middle East, and Africa (EMEA) Companies that Exited (Top 10K) Logo
Europe, Middle East, and Africa (EMEA) Companies that Exited (Top 10K)
36
Biotechnology Companies With More Than $50M in Revenue Logo
Biotechnology Companies With More Than $50M in Revenue
8,134
Biotechnology Companies With More Than 50 Employees Logo
Biotechnology Companies With More Than 50 Employees
3,209
European Union (EU) Health Care Companies (Top 10K) Logo
European Union (EU) Health Care Companies (Top 10K)
2,004
Manufacturing Companies With More Than 500 Employees (Top 10K) Logo
Manufacturing Companies With More Than 500 Employees (Top 10K)
857

Education

Edit Education Section
Rob Koremans studied at Erasmus University Rotterdam.

Recent News and Activity

Edit Recent News and Activity Section
Number of News Articles 10
News•Jan 21, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 1, 2017
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 17, 2016
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 18, 2016
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 24, 2016
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 13, 2016
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 12, 2015
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 28, 2015
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 2, 2015
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 5, 2015
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
View All
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|